Swiss researchers report on metastasis switch
The research team headed by Jörg Standfuss deciphered the structure of the CCR7 receptor that plays a crucial role in the migration of cancer cells....
Rottapharm Biotech: POC in osteoarthritis pain
Results of the proof-of-concept trial suggest the selective imidazoline-2 (I2) receptor agonist CR4056 could be an alternative to the...
Patient's organoids predict response to chemotherapy
The organoid-based test, developed by the group of Emile Voest at Netherland’s Cancer Institute in Amsterdam, in a prospective clinical trial...
Gut bacterial enzyme keeps inflammation away
In studies in human cells, Victor Duarte and colleagues from University of Grenoble, found broad-spectrum antimicrobial activity of a compound...
Novo Nordisk enters haemophilia gene therapy field
Changes in the treatment standard of haemophilia A, such as Roche’s 2017 launch of Hemlibra, have put Novo Nordisk’s revenues (in the US$15.8bn...
Researchers target ferroptosis resistance of cancer cells
In Nature, Sebastian Doll from Marcus Conrad's group at Helmholtz Center Munich and the group of José Pedro Friedmann Angel at University Würzburg,...
Nabriva receives FDA approval for novel antibiotics
The drug, which will be offered both for intravenous and for oral administration, blocks the peptidyl transferase domain of the ribosome. The drug...